Community-acquired pneumonia.
In the past year, community-acquired pneumonia has continued to represent an important area of interest in the literature. Some reports improved our knowledge of epidemiology and outcome. New developments in the technology of molecular biology may soon be incorporated into the laboratory routine to obtain an earlier diagnosis of certain etiologies in individuals with severe episodes. However, the majority of reports on community-acquired pneumonia focus on treatment. New approaches to improve management are directed to reduce costs while maintaining equivalent clinical efficacy. Despite these advances, many areas need further research in the future.